PERsistance of Long-Acting inJEctable CAB+RPV in a Cohort of Virologically-suppressed PLWH: a Real-life Study

NCT07579546 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: Cabotegravir/Rilpivirine

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS